Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Suk Kim

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Biochemical and Biophysical Research Communications|July 18, 2006
A novel protein, Romo1, induces ROS production in the mitochondriaYoung Min Chung, Jun Suk Kim, Young Do Yoo
Medical Hypotheses|October 2, 2007
Properties of the amniotic membrane may be applicable in cancer therapyJae Hong Seo, Yeul Hong Kim, Jun Suk Kim
Cancer Chemotherapy and Pharmacology|March 28, 2008
Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancerJae Hong Seo, Yeul Hong Kim, Jun Suk Kim
Journal of Cardiovascular Computed Tomography|June 20, 2015
Assessment of the regurgitant orifice area in aortic regurgitation with dual-source CT: Comparison with cardiovascular magnetic resonanceSung Min Ko, Jeong Hee Park, Je Kyoun Shin, et al.
Experimental Cell Research|January 10, 2012
Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53Han Na Kang, Sang Cheul Oh, Jun Suk Kim, et al.
Carcinogenesis|January 5, 2008
Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathwayYoung A Yoo, Myoung Hee Kang, Jun Suk Kim, et al.
Biochimica Et Biophysica Acta|January 1, 2008
The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancerYoung A Yoo, Yeul Hong Kim, Jun Suk Kim, et al.
Acta Oncologica (Stockholm, Sweden)|June 18, 2010
High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancerIn Keun Choi, Yeul Hong Kim, Jun Suk Kim, et al.
Cancer Research|May 4, 2005
RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progressionYoung Mi Whang, Yeul Hong Kim, Jun Suk Kim, et al.
Journal of Forensic Sciences|September 4, 2012
Detection of transcribed seal impressions using 3-D pressure tracesJoong Lee, Seong G Kong, Young-Soo Lee, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Biochemical and Biophysical Research Communications|July 18, 2006
A novel protein, Romo1, induces ROS production in the mitochondriaYoung Min Chung, Jun Suk Kim, Young Do Yoo
Medical Hypotheses|October 2, 2007
Properties of the amniotic membrane may be applicable in cancer therapyJae Hong Seo, Yeul Hong Kim, Jun Suk Kim
Cancer Chemotherapy and Pharmacology|March 28, 2008
Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancerJae Hong Seo, Yeul Hong Kim, Jun Suk Kim
Journal of Cardiovascular Computed Tomography|June 20, 2015
Assessment of the regurgitant orifice area in aortic regurgitation with dual-source CT: Comparison with cardiovascular magnetic resonanceSung Min Ko, Jeong Hee Park, Je Kyoun Shin, et al.
Experimental Cell Research|January 10, 2012
Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53Han Na Kang, Sang Cheul Oh, Jun Suk Kim, et al.
Carcinogenesis|January 5, 2008
Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathwayYoung A Yoo, Myoung Hee Kang, Jun Suk Kim, et al.
Biochimica Et Biophysica Acta|January 1, 2008
The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancerYoung A Yoo, Yeul Hong Kim, Jun Suk Kim, et al.
Acta Oncologica (Stockholm, Sweden)|June 18, 2010
High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancerIn Keun Choi, Yeul Hong Kim, Jun Suk Kim, et al.
Cancer Research|May 4, 2005
RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progressionYoung Mi Whang, Yeul Hong Kim, Jun Suk Kim, et al.
Journal of Forensic Sciences|September 4, 2012
Detection of transcribed seal impressions using 3-D pressure tracesJoong Lee, Seong G Kong, Young-Soo Lee, et al.
Pageof 18